Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001171843-16-008620
Filing Date
2016-03-16
Accepted
2016-03-16 16:46:39
Documents
134
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A f10ka_031616p.htm 10-K/A 936190
2 EXHIBIT 23.1 exh_231.htm EX-23.1 2779
3 EXHIBIT 23.2 exh_232.htm EX-23.2 1496
4 EXHIBIT 31.1 exh_311.htm EX-31.1 9325
5 EXHIBIT 31.2 exh_312.htm EX-31.2 9272
6 EXHIBIT 32.1 exh_321.htm EX-32.1 3582
7 EXHIBIT 32.2 exh_322.htm EX-32.2 3553
  Complete submission text file 0001171843-16-008620.txt   9594632

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE scmp-20151231.xml EX-101.INS 1768772
9 XBRL SCHEMA FILE scmp-20151231.xsd EX-101.SCH 123961
10 XBRL CALCULATION FILE scmp-20151231_cal.xml EX-101.CAL 105140
11 XBRL DEFINITION FILE scmp-20151231_def.xml EX-101.DEF 925848
12 XBRL LABEL FILE scmp-20151231_lab.xml EX-101.LAB 752780
13 XBRL PRESENTATION FILE scmp-20151231_pre.xml EX-101.PRE 976493
Mailing Address 805 KING FARM BOULEVARD, SUITE 550 ROCKVILLE MD 20850
Business Address 805 KING FARM BOULEVARD, SUITE 550 ROCKVILLE MD 20850 3019613400
Sucampo Pharmaceuticals, Inc. (Filer) CIK: 0001365216 (see all company filings)

EIN.: 133929237 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-33609 | Film No.: 161510230
SIC: 2834 Pharmaceutical Preparations